Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

School readiness in children with early-onset chronic liver disease: a population-based linked data cohort in England.

Archives of disease in childhood·2026
Same author

Investigating brain maturation, neurodevelopmental and psychiatric outcomes in individuals with early-onset liver disease: protocol of a single-centre observational study.

BMJ open·2025
Same author

Autoimmune hepatitis in children: Guidelines of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN).

Hepatology international·2025
Same author

Pediatric to adult care transfer in rare liver diseases: Recommendations based on insights from a European omnistakeholder event.

JHEP reports : innovation in hepatology·2025
Same author

General and Autism-Related Neurodevelopmental Difficulties in Biliary Atresia.

The Journal of pediatrics·2025
Same author

Update on pediatric liver transplantation in Europe 2022: An ELITA-ESPGHAN report.

Journal of pediatric gastroenterology and nutrition·2025

Related Experiment Video

Updated: May 19, 2026

Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
08:15

Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion

Published on: November 28, 2025

Optimizing outcomes for pediatric recipients.

Marianne Samyn1

  • 1King’s College Hospital, Denmark Hill, London, United Kingdom. marianne.samyn@kingsch.nhs.uk

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|September 4, 2012
PubMed
Summary

Pediatric liver transplantation (LT) allows most children to reach adulthood with good survival rates. However, adolescent transplant recipients require specialized care to address decreased survival and long-term immunosuppression complications.

More Related Videos

Optimization of the Cuff Technique for Murine Heart Transplantation
14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
12:40

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

Published on: September 28, 2022

Related Experiment Videos

Last Updated: May 19, 2026

Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
08:15

Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion

Published on: November 28, 2025

Optimization of the Cuff Technique for Murine Heart Transplantation
14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
12:40

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

Published on: September 28, 2022

Area of Science:

  • Pediatric Hepatology
  • Transplantation Medicine
  • Adolescent Health

Background:

  • Liver transplantation (LT) is a life-saving procedure for children with end-stage liver disease.
  • Long-term outcomes and survivability following pediatric LT are critical considerations for patient management.

Purpose of the Study:

  • To evaluate the long-term survival rates and identify key challenges in pediatric liver transplant recipients.
  • To highlight the need for specialized care pathways for adolescent liver transplant patients.

Main Methods:

  • Analysis of United Network for Organ Sharing (UNOS) data.
  • Review of survival rates and complication profiles in pediatric LT patients.
  • Assessment of risk factors for long-term adverse outcomes.

Main Results:

  • 10-year patient survival rates range from 74% to 84%, with graft survival rates from 62% to 72%.
  • Survival rates decline in adolescent transplant recipients (ages 12-17), emphasizing the need for tailored care.
  • Long-term immunosuppression complications include renal issues, infections, malignancies, and cardiovascular problems.

Conclusions:

  • The majority of pediatric liver transplant recipients now survive into adulthood.
  • Adolescent LT patients require dedicated care and smooth transition to adult services to mitigate decreased survival.
  • Future research should focus on quality of life and health status in long-term pediatric LT survivors, alongside managing medical complications and exploring tolerance-inducing strategies.